Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

GL vs BHFAN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GL Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

GL Overall Winner 6-Pillar Tally: GL 6 – 0 BHFAN Matrix Metrics: GL 8 – 2 BHFAN

As of Nov 20, 2026, Globe Life Inc. (GL) is the stronger overall head-to-head candidate over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GL carries a Unified Composite Score of 34.1/100 (SELL) at $151.65 (9.3x Forward P/E, 25.8% operating margin), whereas BHFAN carries 33.7/100 (SELL) at $9.18 (N/M Forward P/E, 18.4% operating margin).

  • Defensive Composite Rating Caution: Although GL compares more favorably head-to-head, both GL (34.1/100 SELL) and BHFAN (33.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: GL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile BHFAN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GL vs BHFAN
GL NYSE Head-to-Head Winner
Globe Life Inc.
Life Insurance
$151.65
-1.26% 1D
Market Cap $11.6B
TTM Revenue $6.27B
Forward P/E 9.3x
Beta / 30D Vol 0.36β · 34% Vol
Unified Composite Score
34.1 / 100 SELL
Tech 28.0 Fund 47.0 Flow 56.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 32
RSI-14: 32.4 · SMA20: $158.68 · SMA50: $164.08
BHFAN NASDAQ
Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C
Life Insurance
$9.18
-0.65% 1D
Market Cap N/A
TTM Revenue $5.81B
Forward P/E N/M
Beta / 30D Vol 0.36β · 16% Vol
Unified Composite Score
33.7 / 100 SELL
Tech 18.0 Fund 37.0 Flow 50.0 Mom 49.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 18
RSI-14: 17.9 · SMA20: $10.09 · SMA50: $10.65

6-Pillar Scorecard Institutional Category Breakdown (GL 6 – 0 BHFAN)

Columns: Metric · GL · BHFAN
1. Valuation Multiples GL
Forward P/E 9.3x N/M
Trailing P/E 10.3x 0.7x
PEG Ratio 1.30x N/M
EV / Revenue 2.3x N/M
2. Growth & Scale GL
Revenue Growth (YoY) +5.5% -52.7%
Earnings Growth (YoY) -2.3% -34.0%
TTM Revenue (USD) $6.27B $5.81B
Market Cap $11.6B N/A
3. Profitability & Quality GL
Gross Margin 33.1% 16.5%
Operating Margin 25.8% 18.4%
Net Profit Margin 18.9% 11.7%
Return on Equity (ROE) 19.3% 11.9%
4. Balance Sheet & Cash Flow GL
Cash Generation (TTM) $1.33B N/A
Cash Flow Margin 21.3% N/A
Net Cash / Leverage $2.73B Net Debt (0.45x D/E) $87.13 Book/Sh · 11.9% ROE
Dividend Yield 0.81% 14.25%
5. Options & Positioning GL
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 28.2% (6th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat GL
OpEx & R&D Intensity 7.3% of Rev ($458M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Insurance - Life Operator Insurance - Life Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GL (8) vs BHFAN (2)
Institutional Metric GL BHFAN Criterion Row Edge
Market Capitalization
Scale
$11.6B N/A Larger Scale GL
Trailing P/E Ratio
Valuation
10.3x 0.7x Lower Multiple BHFAN
Forward P/E Ratio
Valuation
9.3x N/M Lower Multiple GL
Revenue Growth (YoY)
Growth
+5.5% -52.7% Higher Growth GL
Operating Margin (TTM)
Profitability
25.8% 18.4% Higher Margin GL
Net Profit Margin
Profitability
18.9% 11.7% Higher Margin GL
Return on Equity (ROE)
Capital Efficiency
19.3% 11.9% Higher ROE GL
52-Week Range Position
Momentum
36% ($129–$192) 0% ($9–$14) Stronger Trend GL
Beta / 30D Volatility
Risk Regime
0.36β · 34% Vol 0.36β · 16% Vol Lower Realized Risk BHFAN
Unified Institutional Score
Composite Signal
34.1 / 100 (SELL) 33.7 / 100 (SELL) Higher Composite GL
Trailing 12M Revenue (USD)
Operating Scale
$6.27B $5.81B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
33.1% 16.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.30x PEG · 2.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.33B ($2.73B Net Debt (0.45x D/E)) N/A ($87.13 Book/Sh · 11.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GL +2.29 pp
GL: -9.95% · BHFAN: -12.24%
3M Horizon GL +8.99 pp
GL: -12.41% · BHFAN: -21.4%
6M Horizon GL +23.89 pp
GL: -2.96% · BHFAN: -26.85%
1Y Horizon GL +44.99 pp
GL: +15.99% · BHFAN: -29.0%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GL vs BHFAN. Trailing 12-month operating profitability (GL 25.8% vs BHFAN 18.4%) and valuation multiples (GL 9.3x vs BHFAN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.27B
Gross Margin33.1%
Op. Margin25.8%
ROE / Fwd P/E19.3% · 9.3x
BHFAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.81B
Gross Margin16.5%
Op. Margin18.4%
ROE / Fwd P/E11.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GL CONSOLIDATION
106d in phase · OBV DISTRIBUTION
Current IV 28.2%
IV Percentile 6th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact GL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHFAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHFAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GL Moat Profile Scale & Operating Efficiency Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with $11.6B market capitalization and 25.8% operating margin.
OpEx & R&D Reinvestment 7.3% of Rev ($458M)
90D Engineering Disclosures 0 Published
BHFAN Moat Profile Scale & Operating Efficiency Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with N/A market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GL vs BHFAN Key Questions & Quantitative Answers

As of Nov 20, 2026, Globe Life Inc. (GL) is the stronger overall head-to-head candidate over Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GL carries a Unified Composite Score of 34.1/100 (SELL) at $151.65 (9.3x Forward P/E, 25.8% operating margin), whereas BHFAN carries 33.7/100 (SELL) at $9.18 (N/M Forward P/E, 18.4% operating margin). Defensive Composite Rating Caution: Although GL compares more favorably head-to-head, both GL (34.1/100 SELL) and BHFAN (33.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: GL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile BHFAN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GL leads the Growth & Scale pillar: GL posts +5.5% YoY revenue growth and -2.3% YoY earnings growth on $6.27B TTM revenue (33.1% gross margin, 25.8% operating margin), compared with BHFAN at -52.7% YoY revenue growth and -34.0% YoY earnings growth on $5.81B TTM revenue (16.5% gross margin, 18.4% operating margin). On trailing 12-month operating scale, GL generates $6.27B in USD-normalized revenue versus $5.81B for BHFAN. In operating R&D and SG&A reinvestment, GL deploys 7.3% of Rev ($458M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BHFAN.

GL screens cheaper on headline valuation multiples. GL trades at 9.3x Forward P/E, 10.3x Trailing P/E, 1.30x PEG, and 2.3x EV/Revenue (21.3% FCF margin), whereas BHFAN trades at N/M Forward P/E, 0.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GL (19.3% ROE) versus BHFAN (11.9% ROE) capital efficiency.

In options market volatility and institutional positioning, GL carries 28.2% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.36β · 34% Vol realized risk). By comparison, BHFAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 16% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.